Genetic insights into moderate-to-severe asthma

被引：8
|
作者：
Nadif, Rachel [1 ]
机构：
[1] Hop Paul Brousse, INSERM, U1168, Aging & Chron Dis,Epidemiol & Publ Hlth Approache, F-94807 Villejuif, France
来源：
LANCET RESPIRATORY MEDICINE | 2019年 / 7卷 / 01期
关键词：
D O I：
10.1016/S2213-2600(18)30447-8
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：2 / 3
页数：2
相关论文
共 50 条
  • [21] Moderate-to-severe persistent asthma is undertreated in a pediatric medicaid population
    Naureckas, SM
    Thomas, S
    Naureckas, ET
    PEDIATRIC RESEARCH, 2000, 47 (04) : 155A - 155A
  • [22] Another Rescue Therapy Option for Patients with Moderate-to-Severe Asthma
    Schatz, Michael
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (22): : 2139 - 2140
  • [23] Dupilumab in children with moderate-to-severe asthma: A cost utility analysis
    Buendia, Jefferson A.
    Patino, Diana G.
    PEDIATRIC PULMONOLOGY, 2022, 57 (10) : 2313 - 2319
  • [24] Dupilumab in the management of moderate-to-severe asthma: the data so far
    Barranco, Pilar
    Phillips-Angles, Elsa
    Dominguez-Ortega, Javier
    Quirce, Santiago
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 : 1139 - 1149
  • [25] Evaluating Proper Inhaler Technique in Children with Moderate-to-Severe Asthma
    Bozen, Alexandria
    Blumenstock, Jesse A.
    Kanaley, Madeleine K.
    Boon, Kathy L.
    Szkodon, Jolanta W.
    Newmark, Pamela J.
    Chadha, Avneet S.
    Kan, Kristin
    Vojta, Deneen
    Gupta, Ruchi S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB196 - AB196
  • [26] Use of dupilumab on the treatment of moderate-to-severe asthma: a systematic review
    Bassani, Cintia
    Rossi, Larissa
    Siveri, Kaian
    Sferelli, Rafaella Lorenzon
    Saraiva, Leonardo
    Tanno, Luciana Kase
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2019, 65 (09): : 1223 - 1228
  • [27] Addition of salmeterol to fluticasone propionate treatment in moderate-to-severe asthma
    Ind, PW
    Dal Negro, R
    Colman, NC
    Fletcher, CP
    Browning, D
    James, MH
    RESPIRATORY MEDICINE, 2003, 97 (05) : 555 - 562
  • [28] Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma
    Corren, Jonathan
    Castro, Mario
    O'Riordan, Thomas
    Hanania, Nicola A.
    Pavord, Ian D.
    Quirce, Santiago
    Chipps, Bradley E.
    Wenzel, Sally E.
    Thangavelu, Karthinathan
    Rice, Megan S.
    Harel, Sivan
    Jagerschmidt, Alexandre
    Khan, Asif H.
    Kamat, Siddhesh
    Maroni, Jaman
    Rowe, Paul
    Lu, Yufang
    Amin, Nikhil
    Pirozzi, Gianluca
    Ruddy, Marcella
    Graham, Neil M. H.
    Teper, Ariel
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (02): : 516 - 526
  • [29] Dupilumab Efficacy in Patients With Uncontrolled, Moderate-to-Severe Allergic Asthma
    Miller, Mechelle A.
    Davis, Karla L.
    PEDIATRICS, 2020, 146 : S375 - S375
  • [30] Omalizumab: An update on efficacy and safety in moderate-to-severe allergic asthma
    Chipps, Bradley E.
    Figliomeni, Maria
    Spector, Sheldon
    ALLERGY AND ASTHMA PROCEEDINGS, 2012, 33 (05) : 377 - 385
12345